Engineering advanced membranes using DNA technology
DNA nanotechnology enabled high-precision membrane engineering
['FUNDING_OTHER'] · YALE UNIVERSITY · NIH-10932106
This study is working on building special membranes that act like the ones in our cells to help us learn how proteins work with them, which could lead to better ways to deliver medicines and treat diseases.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | YALE UNIVERSITY (nih funded) |
| Locations | 1 site (NEW HAVEN, UNITED STATES) |
| Trial ID | NIH-10932106 on ClinicalTrials.gov |
What this research studies
This research focuses on creating highly precise membrane structures that are essential for various cellular functions such as nutrient uptake and signal transduction. By utilizing DNA nanotechnology, the project aims to develop membranes with controlled properties that can mimic natural cellular environments. This approach allows for detailed study of how proteins interact with these membranes, which is crucial for understanding cellular processes. Patients may benefit from advancements in drug delivery systems and therapies that target cellular mechanisms more effectively.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research include individuals with conditions that affect cellular communication or require advanced drug delivery methods.
Not a fit: Patients with conditions unrelated to cellular mechanisms or those who do not require innovative drug delivery solutions may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved drug delivery systems and therapies that enhance cellular communication and function.
How similar studies have performed: Other research has shown promise in using nanotechnology for membrane engineering, indicating potential success for this innovative approach.
Where this research is happening
NEW HAVEN, UNITED STATES
- YALE UNIVERSITY — NEW HAVEN, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: LIN, CHENXIANG — YALE UNIVERSITY
- Study coordinator: LIN, CHENXIANG
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.